APA (7th ed.) Citation

T, N., H, T., M, O., M, T., Y, T., & H, N. (2021). GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice. Dove Medical Press.

Chicago Style (17th ed.) Citation

T, Nakamura, Tanimoto H, Okamoto M, Takeuchi M, Tsubamoto Y, and Noda H. GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice. Dove Medical Press, 2021.

MLA (8th ed.) Citation

T, Nakamura, et al. GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice. Dove Medical Press, 2021.